Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Completed

Conditions studied: Hiv

In brief

BACKGROUND: Long-acting injectable antiretroviral therapy (LAI-ART) is poised to revolutionize HIV treatment and prevention. Community pharmacies could serve as another place for people with HIV to get their ART injections. However, pharmacist and healthcare practitioner attitudes towards pharmacist administration of LAI-ART are understudied. Financial and human resources, pharmacist training, or changes in workflow have not been outlined. Little is known about whether patients will accept ART injections given in pharmacies. OBJECTIVE: The purpose of this project is to address the above knowledge gaps. The information generated can assist in the development of tools that can help scale community pharmacy-based delivery of LAI-ART. METHODS: Using a mixed-methods approach to better understand the pre-implementation environment, the study will employ electronic surveys and will administer semi-structured interviews via telephone for three key stakeholder groups: HIV clinic staff members, community pharmacists, and persons with HIV. Surveys will assess the appropriateness, acceptability, and feasibility of LAI-ART administration in community pharmacies. A semi-structured interview guide has been developed using constructs from the Consolidated Framework for Implementation Research (CFIR). Comparisons between and across stakeholder groups will be performed, looking for common themes as well as discrepancies.

Key facts

Study ID

NCT05152953

Run by

University of California, San Francisco

People needed

63

Starts

2022-06-08

Expected to finish

2023-11-15

Last updated by the study team

2023-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18 years or over
• Access to telephone (at minimum), access to internet/email preferred
• Pharmacy staff members must meet the following additional criteria:
• Currently employed at a community (retail, independent, specialty, chain) or outpatient health system pharmacy.
• Self-reported likelihood or potential to be involved with some aspect (e.g. billing, scheduling, administering, advertising, training) of implementing long-acting injectable antiretroviral therapy in pharmacies.
• Patients (persons with HIV) must meet the following additional criteria:
• Self-reported diagnosis of HIV, currently taking antiretroviral therapy (LAI-ART or oral or other)
• Self-reported undetectable HIV-1 viral load (Note: if potential participant does not know they will be encouraged to contact their health care provider to ask)
• Access to telephone
• Clinic staff must meet the following additional criteria:
• Currently employed in a clinic practice where HIV-positive patients comprise > 10% of clinic population
• Self-reported likelihood or potential to be involved with some aspect (e.g. billing, scheduling, administering, advertising, training, referring patients to other clinics) of implementing long-acting injectable antiretroviral therapy in their own clinic setting.

You may not qualify if…

• Pharmacy staff with no forseeable involvement in implementation of a long-acting injectable antiretroviral therapy administration program.
• Patients/persons who are not diagnosed with HIV, who are candidates for long-acting cabotegravir as HIV pre-exposure prophylaxis.
• Clinic staff members with no current or forseeable involvement in supporting patients to receive long-acting injectable antiretroviral therapies.
• Persons who do not speak English to a degree that would allow full comprehension of and participation in the study.

Where it is running

• Auburn University Harrison School of Pharmacy — Auburn, Alabama, United States
• University of California San Francisco School of Pharmacy — San Francisco, California, United States
• Nova Southeastern University College of Pharmacy — Fort Lauderdale, Florida, United States
• Texas A&M Irma Lerma Rangel College of Pharmacy — Kingsville, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.